FDA Inspection 885331 — Joslin Diabetes Center Committee on Human Studies

Joslin Diabetes Center Committee on Human Studies — FEI 1283624

The FDA completed an inspection of Joslin Diabetes Center Committee on Human Studies on June 27, 2014 in Boston, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 27, 2014
Fiscal Year
2014
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional Details

IRB

Citations

IDCFRDescription
729721 CFR 56.109(b)Information given to subjects